< Back to previous page
Researcher
Zeger Debyser
- Disciplines:Laboratory medicine, Microbiology, Systems biology, Biomaterials engineering, Biological system engineering, Biomechanical engineering, Other (bio)medical engineering, Environmental engineering and biotechnology, Industrial biotechnology, Other biotechnology, bio-engineering and biosystem engineering
Affiliations
- Molecular Virology and Gene Therapy (Division)
Responsible
From1 Jan 2012 → Today - Molecular Virology and Gene Therapy (Division)
Member
From1 Jan 2013 → Today - Faculty of Medicine, Kulak Kortrijk Campus (Faculty)
Member
From1 Oct 2003 → 29 Feb 2008 - Faculty of Medicine (Faculty)
Member
From1 Oct 1999 → 30 Sep 2003
Projects
11 - 20 of 77
- Epigenetic regulation of HIV transcription: Towards a block-and- lock functional cureFrom16 Jul 2021 → TodayFunding: FWO fellowships
- Towards a functional cure of HIV infectionFrom9 Feb 2021 → 31 May 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Cystic fibrosis is not only an ion channel defect - investigation of the role of senescence in chronic inflammation as a novel therapeutic strategyFrom17 Dec 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- OrganID: Organ-derived complex 2D/3D cultures in human diseaseFrom1 Oct 2020 → TodayFunding: FWO Strategic Basic Research (SBO)
- A gene editing strategy for refractory CFTR mutations causing cystic fibrosis.From3 Sep 2020 → 31 Aug 2023Funding: Other federal public and semi-governmental institutions
- Investigation of the SARS-CoV-2.From1 Sep 2020 → 31 Aug 2022Funding: Foreign Nonprofit organisations and equivalents
- Identification of novel host factors regulating L1 retrotranspositionFrom5 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- EngelsFrom3 Aug 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Crystallographic facility for target-based drug designFrom1 May 2020 → TodayFunding: FWO International research infrastructure (IRI)
- Strategies against persistent HIV-1 reservoirs(SAPHIR)From1 Jan 2020 → 31 Dec 2023Funding: FWO Strategic Basic Research (SBO)
Publications
1 - 10 of 305
- New latency-promoting agents for a block-and-lock functional cure strategy.(2024)
Authors: Eline Pellaers, Zeger Debyser
- The Impact of Lens Epithelium-Derived Growth Factor p75 Dimerization on Its Tethering Function(2024)
Authors: Siska Van Belle, Zeger Debyser
- The HIV-2 OGH double reporter virus shows that HIV-2 is less cytotoxic and less sensitive to reactivation from latency than HIV-1 in cell culture(2023)
Authors: Anne Bruggemans, Zeger Debyser
- Particle-based phasor-FLIM-FRET resolves protein-protein interactions inside single viral particles(2023)
Authors: Quinten Coucke, Guillermo Solís Fernández, Johan Hofkens, Zeger Debyser, Jelle Hendrix
- Development of novel therapeutic strategies for rare CFTR mutations causing severe cystic fibrosis(2023)
Authors: Marjolein Ensinck, Zeger Debyser, Christiane De Boeck, Marianne Carlon
- Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV-Based Vectors and for a Cure for HIV-1 Infection(2023)
Authors: Eline Pellaers, Anayat Bhat, Frauke Christ, Zeger Debyser
- Development of a new therapeutic strategy for the treatment of MLL-rearranged acute leukemia(2022)
Authors: Siska Van Belle, Zeger Debyser, Frauke Christ
- Single-Cell Imaging Shows That the Transcriptional State of the HIV-1 Provirus and Its Reactivation Potential Depend on the Integration Site(2022)
Authors: Zeger Debyser
- Design, synthesis, in silico studies, and antiproliferative evaluations of novel indolin-2-one derivatives containing 3-hydroxy-4-pyridinone fragment(2022)
Authors: Siska Van Belle, Zeger Debyser, Frauke Christ
- Expansion microscopy allows high resolution single cell analysis of epigenetic readers(2022)
Authors: Boris Louis, Susana Neves Rocha, Thierry Voet, Zeger Debyser, Johan Hofkens
Patents
1 - 9 of 9
- Functional cure of retroviral infection (Inventor)
- Functional cure of retroviral infection (Inventor)
- Thieno[2,3-b]pyridine derivatives as viral replication inhibitors (Inventor)
- Functional cure of retroviral infection (Inventor)
- Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors (Inventor)
- ;Antiviral compounds (Inventor)
- THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS (Inventor)
- NOVEL ANTIVIRAL COMPOUNDS (Inventor)
- VIRAL REPLICATION INHIBITORS (Inventor)